Increased production of TGF-β1 from sputum cells of COPD: Relationship with airway obstruction

[en] Chronic obstructive pulmonary disease (COPD) is a chronic airway disease characterized by a profound airway remodelling that leads to airway obstruction. A role for transforming growth factor-β1 (TGF-β1) has been proposed in airway remodelling of COPD. Regarding the TGF-β1 production at local level, the results seemed to be controversial. In this study, an original model of sputum cell culture thought to maintain important cells interactions, was used. We investigated the production of TGF-β1 from sputum cell culture in 33 COPD encompassing the whole severity spectrum and compared the results with those found in 39 healthy controls. Sputum was induced by inhalation of saline, the cellular fraction cultured for 24 h and the spontaneous production of total TGF-β1 was assessed by ELISA. Using, a TGF-β1 reporter cell assay, we also compared the levels of active and total TGF-β1 in the sputum cell culture supernatants of COPD and controls. Moreover, as a combination of tumor necrosis factor-α (TNF-α) and TGF-β1 have been shown to have a cumulative impact on the severity of airflow limitation in COPD, the TNF-α release was also measured in a representative subgroup of patients. Our results indicated that the use of sputum cell culture was a reliable and reproducible method to assess TGF-β1 production at airway level. Sputum cells from COPD produced greater amount of total TGF-β1 than those of healthy controls (p < 0.001). This result was confirmed using the cell reporter assay which also showed a higher level of active TGF-β1 in the COPD group compared to controls. In addition, total TGF-β1 production was increased according to GOLD stage and was inversely related to FEV1/FVC ratio (p < 0.05). By contrast, the production of this growth factor was not correlated with the functional markers of emphysema nor with demographic characteristics such as age, BMI or smoking status. Interestingly, the production of total TGF-β1 was inversely related to that of TNF-α (r = −0.53, p < 0.05) which was decreased in COPD. In summary, COPD patients displayed a raised production of total and active TGF-β1 from their airway cells. Total TGF-β1 correlates with the severity of airway obstruction without evidence of a link with emphysema.. © 2017 Elsevier Ltd

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Godinas, L.; Department of Pneumology, CHU Liege, I3 GIGA Research, University of Liege, Avenue de l'hopital, 4000 Liège, Sart Tilman, Belgium

Corhay, Jean-Louis ; Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques

HENKET, Monique ; Centre Hospitalier Universitaire de Liège - CHU > Service de pneumologie - allergologie

GUIOT, Julien ; Centre Hospitalier Universitaire de Liège - CHU > Service de pneumologie - allergologie

Louis, Renaud ; Université de Liège - ULiège > Département des sciences cliniques > Pneumologie - Allergologie

MOERMANS, Catherine ; Centre Hospitalier Universitaire de Liège - CHU > Service de pneumologie - allergologie

Language :

English

Title :

Increased production of TGF-β1 from sputum cells of COPD: Relationship with airway obstruction

Publication date :

November 2017

Journal title :

Cytokine

ISSN :

1043-4666

eISSN :

1096-0023

Publisher :

Academic Press

Volume :

Pages :

1-8

Peer reviewed :

Peer Reviewed verified by ORBi

Funders :

F.R.S.-FNRS - Fonds de la Recherche Scientifique [BE]

Available on ORBi :

since 27 August 2018

Statistics

Number of views

118 (5 by ULiège)

Number of downloads

102 (3 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Rabe, K.F., Hurd, S., Anzueto, A., Barnes, P.J., Buist, S.A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., Zielinski, J., Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 176 (2007), 532–555, 10.1164/rccm.200703-456SO.
Jeffery, P.K., Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 1 (2004), 176–183, 10.1513/pats.200402-009MS.
Hogg, J.C., Chu, F., Utokaparch, S., Woods, R., Elliott, W.M., Buzatu, L., Cherniack, R.M., Rogers, R.M., Sciurba, F.C., Coxson, H.O., The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350 (2004), 2645–2653.
Chung, K.F., Adcock, I.M., Multifaceted mechanisms in COPD: Inflammation, immunity, and tissue repair and destruction. Eur. Respir. J. 31 (2008), 1334–1356, 10.1183/09031936.00018908.
Blobe, G.C., Schiemann, W.P., Lodish, H.F., Role of transforming growth factor ß in human disease. N. Engl. J. Med. 342 (2000), 1350–1358.
Lee, K.-Y., Ho, S.-C., Lin, H.-C., Lin, S.-M., Liu, C.-Y., Huang, C.-D., Wang, C.-H., Chung, K.F., Kuo, H.-P., Neutrophil-derived elastase induces TGF-beta1 secretion in human airway smooth muscle via NF-kappaB pathway. Am. J. Respir. Cell Mol. Biol. 35 (2006), 407–414, 10.1165/rcmb.2006-0012OC.
Brand, O.J., Somanath, S., Moermans, C., Yanagisawa, H., Hashimoto, M., Cambier, S., Markovics, J., Bondesson, A.J., Hill, A., Jablons, D., Wolters, P., Lou, J., Marks, J.D., Baron, J.L., Transforming growth factor-β and interleukin-1β signaling pathways converge on the chemokine CCL20 promoter. J. Biol. Chem. 290 (2015), 14717–14728.
Yang, Y.C., Zhang, N., Van Crombruggen, K., Hu, G.H., Hong, S.L., Bachert, C., Transforming growth factor-beta1 in inflammatory airway disease: a key for understanding inflammation and remodeling. Allergy Eur. J. Allergy Clin. Immunol. 67 (2012), 1193–1202, 10.1111/j.1398-9995.2012.02880.x.
Barnes, P.J., The cytokine network in asthma and chronic obstructive pulmonary disease. J. Clin. Invest. 118 (2008), 3546–3556, 10.1172/JCI36130.
Quaedvlieg, V., Henket, M., Sele, J., Louis, R., Cytokine production from sputum cells in eosinophilic versus non-eosinophilic asthmatics. Clin. Exp. Immunol. 143 (2006), 161–166, 10.1111/j.1365-2249.2005.02968.x.
Dentener, M.A., Differences in local versus systemic TNF production in COPD: inhibitory effect of hyaluronan on LPS induced blood cell TNF release. Thorax 61 (2006), 478–484, 10.1136/thx.2005.053330.
Bettiol, J., Sele, J., Henket, M., Louis, E., Malaise, M., Bartsch, P., Louis, R., Cytokine production from sputum cells after allergenic challenge in IgE-mediated asthma. Allergy 57 (2002), 1145–1150, 10.1034/j.1398-9995.2002.23586.x.
Ji, J., von Schéele, I., Bergström, J., Billing, B., Dahlén, B., Lantz, A.-S., Larsson, K., Palmberg, L., Compartment differences of inflammatory activity in chronic obstructive pulmonary disease. Respir. Res., 15, 2014, 104, 10.1186/s12931-014-0104-3.
Chiang, C.-H., Chuang, C.-H., Liu, S.-L., Transforming growth factor-β1 and tumor necrosis factor-α are associated with clinical severity and airflow limitation of COPD in an additive manner. Lung 192 (2014), 95–102, 10.1007/s00408-013-9520-2.
Global Strategy for the Diagnosis, Management and Prevention of COPD, Glob. Initiat. Chronic Obstr. Lung Dis. 2017 (n.d.) http://www.goldcopd.org.
Moermans, C., Poulet, C., Henket, M., Bonnet, C., Willems, E., Baron, F., Beguin, Y., Louis, R., Lung function and airway inflammation monitoring after hematopoietic stem cell transplantation. Respir. Med. 107 (2013), 2071–2080, 10.1016/j.rmed.2013.10.013.
Wanger, J., Clausen, J.L., Coates, A., Pedersen, O.F., Brusasco, V., Burgos, F., Casaburi, R., Crapo, R., Enright, P., van der Grinten, C.P.M., Gustafsson, P., Hankinson, J., Jensen, R., Johnson, D.C., MacIntyre, N., McKay, R., Miller, M.R., Navajas, D., Pellegrino, R., Veigi, G., Standardisation of the measurement of lung volumes. Eur. Respir. J. 26 (2005), 511–522, 10.1183/09031936.05.00035005.
Miller, M.R., Crapo, R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Enright, P., van der Grinten, C.P.M., Gustafsson, P., Jensen, R., Johnson, D.C., MacIntyre, N., McKay, R., Navajas, D., Pedersen, O.F., Pellegrino, R., Viegi, G., Wanger, J., ATS/ERS Task Force, General considerations for lung function testing. Eur. Respir. J. Off. J. Eur. Soc. Clin. Respir. Physiol. 26 (2005), 153–161, 10.1183/09031936.05.00034505.
MacIntyre, N., Crapo, R.O., Viegi, G., Johnson, D.C., van der Grinten, C.P.M., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Enright, P., Gustafsson, P., Hankinson, J., Jensen, R., McKay, R., Miller, M.R., Navajas, D., Pedersen, O.F., Pellegrino, R., Wanger, J., Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur. Respir. J. 26 (2005), 720–735, 10.1183/09031936.05.00034905.
Moermans, C., Heinen, V., Nguyen, M., Henket, M., Sele, J., Manise, M., Corhay, J.L., Louis, R., Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease. Cytokine 56 (2011), 298–304, 10.1016/j.cyto.2011.07.010.
Delvaux, M., Henket, M., Lau, L., Kange, P., Bartsch, P., Djukanovic, R., Louis, R., Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma. Thorax 59 (2004), 111–115, 10.1136/thorax.2003.011130.
Abe, M., Harpel, J.G., Metz, C.N., Nunes, I., Loskutoff, D.J., Rifkin, D.B., An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 216 (1994), 276–284, 10.1006/abio.1994.1042.
Vignola, A.M., Chanez, P., Chiappara, G., Merendino, A., Pace, E., Rizzo, A., la Rocca, A.M., Bellia, V., Bonsignore, G., Bousquet, J., Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am. J. Respir. Crit. Care Med. 156 (1997), 591–599, 10.1164/ajrccm.156.2.9609066.
Mak, J.C.W., Chan-Yeung, M.M.W., Ho, S.P., Chan, K.S., Choo, K., Yee, K.S., Chau, C.H., Cheung, A.H.K., Ip, M.S.M., Elevated plasma TGF-beta1 levels in patients with chronic obstructive pulmonary disease. Respir. Med. 103 (2009), 1083–1089, 10.1016/j.rmed.2009.01.005.
W.I. de Boer, a van Schadewijk, J.K. Sont, H.S. Sharma, J. Stolk, P.S. Hiemstra, J.H. van Krieken, Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med. 158 (1998) 1951–1957, doi:10.1164/ajrccm.158.6.9803053.
M. Vignola, P. Chanez, G. Chiappara, Merendino, E. Zinnanti, J. Bousquet, V. Bellia, G. Bonsignore, Release of transforming growth factor-beta (TGF-beta) and fibronectin by alveolar macrophages in airway diseases, Clin. Exp. Immunol. 106 (1996) 114–119 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2200550&tool=pmcentrez&rendertype=abstract.
R. Pons, J. Sauleda, Noguera, J. Pons, B. Barceló, Fuster, G.N. Agustí, Decreased macrophage release of TGF-beta and TIMP-1 in chronic obstructive pulmonary disease, Eur. Respir. J. 26 (2005) 60–66, doi: 10.1183/09031936.05.00045504.
Li, X.N., Pan, X., Qiu, D., Imbalances of Th17 and Treg cells and their respective cytokines in COPD patients by disease stage. Int. J. Clin. Exp. Med. 7 (2014), 5324–5329.
Li, H., Liu, Q., Jiang, Y., Zhang, Y., Zhang, Y., Xiao, W., Disruption of th17/treg balance in the sputum of patients with chronic obstructive pulmonary disease. Am. J. Med. Sci. 349 (2015), 392–397, 10.1097/MAJ.0000000000000447.
Ziora, D., Dworniczak, S., Kaczmarczyk, G., Jastrzebski, D., Krzywiecki, A., Kozielski, J., Correlation of exhaled nitric oxide with nitrogen oxides and selected cytokines in induced sputum of chronic obstructive pulmonary disease patients. J. Physiol. Pharmacol. 58:Suppl 5 (2007), 791–799.
Moermans, C., Bonnet, C., Willems, E., Baron, F., Nguyen, M., Henket, M., Sele, J., Corhay, J.L., Beguin, Y., Louis, R., Sputum cytokine levels in patients undergoing hematopoietic SCT and comparison with healthy subjects and COPD: a pilot study. Bone Marrow Transpl. 49 (2014), 1382–1388, 10.1038/bmt.2014.164.
Khan, S.A., Joyce, J., Tsuda, T., Quantification of active and total transforming growth factor-β levels in serum and solid organ tissues by bioassay. BMC Res. Notes, 5, 2012, 636, 10.1186/1756-0500-5-636.
Stoll, P., Wuertemberger, U., Bratke, K., Zingler, C., Virchow, J.C., Lommatzsch, M., Stage-dependent association of BDNF and TGF-beta1 with lung function in stable COPD. Respir. Res., 13, 2012, 116, 10.1186/1465-9921-13-116.
Takizawa, H., Tanaka, M., Takami, K., Ohtoshi, T., Ito, K., Satoh, M., Okada, Y., Yamasawa, F., Nakahara, K., Umeda, A., Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am. J. Respir. Crit. Care Med. 163 (2001), 1476–1483, 10.1164/ajrccm.163.6.9908135.
S.R. Rutgers, D.S. Postma, N.H. Ten Hacken, H.F. Kauffman, T.W. Van der Mark, G.H. Koeter, W. Timens, Ongoing airway inflammation in patients with COPD who do not currently smoke, Thorax (2000) 12–18, doi:10.1136/thorax.55.1.12.
Camoretti-Mercado, B., Solway, J., Transforming growth factor-beta1 and disorders of the lung. Cell Biochem. Biophys. 43 (2005), 131–148, 10.1385/CBB:43:1:131.
Hodge, S.J., Hodge, G.L., Reynolds, P.N., Scicchitano, R., Holmes, M., Increased production of TGF-beta and apoptosis of T lymphocytes isolated from peripheral blood in COPD. Am. J. Physiol. Lung Cell. Mol. Physiol. 285 (2003), L492–L499, 10.1152/ajplung.00428.2002.
Ashcroft, G.S., Bidirectional regulation of macrophage function by TGF-beta. Microbes Infect. 1 (1999), 1275–1282, 10.1016/S1286-4579(99)00257-9.
Cabello, H., Torres, A., Celis, R., El-Ebiary, M., Puig De La Bellacasa, J., Xaubet, A., González, J., Agustí, C., Soler, N., Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study. Eur. Respir. J. 10 (1997), 1137–1144, 10.1183/09031936.97.10051137.
Di Francia, M., Barbier, D., Mege, J.L., Orehek, J., Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am. J. Respir. Crit Care Med. 150 (1994), 1453–1455.
Pinto-Plata, V., Casanova, C., Müllerova, H., de Torres, J.P., Corado, H., Varo, N., Cordoba, E., Zeineldine, S., Paz, H., Baz, R., Divo, M., Cortopassi, F., Celli, B.R., Inflammatory and repair serum biomarker pattern. Association to clinical outcomes in COPD. Respir. Res., 13, 2012, 71, 10.1186/1465-9921-13-71.
Hacievliyagil, S.S., Gunen, H., Mutlu, L.C., Karabulut, A.B., Temel, I., Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease. Respir. Med. 100 (2006), 846–854, 10.1016/j.rmed.2005.08.022.